AFP and hepatocellular carcinoma: Therefore, it is now widely established that all these patients should undergo HCC surveillance regardless of viral eradication, i.e., an abdominal ultrasound every six months (with or without α-fetoprotein (AFP) testing), despite any fibrosis regression [70,71,72,73].